Literature DB >> 9627284

Success rate with repeated cycles of in vitro fertilization-embryo transfer.

D R Meldrum1, K M Silverberg, M Bustillo, L Stokes.   

Abstract

OBJECTIVE: To analyze data from a large multicenter study to determine whether pregnancy and delivery rates decrease with repeated IVF-ET cycles.
DESIGN: Multicenter retrospective study.
SETTING: Participating centers from the Society of Assisted Reproductive Technology. PATIENT(S): Fifty-four centers contributed 4,043 cycles of oocyte retrieval for uterine transfer. INTERVENTION(S): Oocyte retrieval for uterine transfer. MAIN OUTCOME MEASURE(S): Pregnancy and delivery rates, analyzed according to age, program success rate, and whether the program was doing assisted hatching. RESULT(S): Pregnancy and delivery rates for cycles 1, 2, 3, 4, and >4 were 33.7% and 27.0%, 33.9% and 27.4%, 28.9% and 23.4%. 25.9% and 16.1%, and 21.0% and 15.4%, respectively. The pregnancy rate decreased significantly for >4 cycle; delivery rate decreased significantly for cycles 4 and >4. Assisted hatching was strongly related to better odds of pregnancy (OR, 1.50) and delivery (OR, 1.44) in women under age 40, and for pregnancy (1.64) in women age 40-42 years. CONCLUSION(S): Success rates do not decrease markedly with repeated IVF attempts, and the decrease did not change with program success rate, suggesting the IVF population is not markedly heterogeneous. Uncontrolled studies of new treatments for cycle repeaters cannot assume that success rate is poor without a treatment change.

Entities:  

Mesh:

Year:  1998        PMID: 9627284     DOI: 10.1016/s0015-0282(98)00083-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  An analysis of spontaneous hatching in a human endometrial epithelial coculture system: is assisted hatching justified?

Authors:  A Mercader; C Simón; A Galán; R Herrer; C Albert; J Remohí; A Pellicer
Journal:  J Assist Reprod Genet       Date:  2001-06       Impact factor: 3.412

2.  Interval double transfer improves treatment success in patients with repeated IVF/ET failures.

Authors:  B Almog; I Levin; I Wagman; R Kapustiansky; T Schwartz; N Mey-Raz; A Amit; F Azem
Journal:  J Assist Reprod Genet       Date:  2008-08-14       Impact factor: 3.412

3.  Should zygote intrafallopian transfer be offered to all patients with unexplained repeated in-vitro fertilization cycle failures?

Authors:  Itai Gat; Jacob Levron; Gil Yerushalmi; Jehoshua Dor; Masha Brengauz; Raoul Orvieto
Journal:  J Ovarian Res       Date:  2014-01-20       Impact factor: 4.234

4.  The number of previous failed embryo transfer cycles is an independent factor affecting implantation rate in women undergoing IVF/ICSI treatment: A retrospective cohort study.

Authors:  Yangyang Wang; Yichao Tian; Liu Liu; Tin-Chiu Li; Xiaomei Tong; Haiyan Zhu; Songying Zhang
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  Live Birth Rate in Women with Recurrent Pregnancy Loss after In Vitro Fertilization with Concomitant Intravenous Immunoglobulin and Prednisone.

Authors:  Pia Egerup; Henriette Svarre Nielsen; Anders Nyboe Andersen; Ole Bjarne Christiansen
Journal:  J Clin Med       Date:  2022-03-29       Impact factor: 4.241

6.  The impact of endometriosis, endometrioma and ovarian cystectomy on assisted reproductive technology.

Authors:  Keiji Kuroda; Mari Kitade; Iwaho Kikuchi; Jun Kumakiri; Shozo Matsuoka; Masako Kuroda; Satoru Takeda
Journal:  Reprod Med Biol       Date:  2009-06-26

7.  Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes.

Authors:  Elodie Scalici; Shaliha Bechoua; Karine Astruc; Laurence Duvillard; Thomas Gautier; Véronique Drouineaud; Clément Jimenez; Samir Hamamah
Journal:  Reprod Biol Endocrinol       Date:  2016-05-21       Impact factor: 5.211

8.  Two-year outcome after recurrent implantation failure: prognostic factors and additional interventions.

Authors:  Christiane Kling; Andreas Schmutzler; Georg Wilke; Jürgen Hedderich; Dieter Kabelitz
Journal:  Arch Gynecol Obstet       Date:  2008-01-12       Impact factor: 2.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.